Immunization News and Research

RSS

Study: Understanding the reasons behind vaccine hesitancy is key to boosting global uptake of immunization

Exploring complex reasons behind hesitancy for new vaccinations and better education for healthcare professionals is key to boosting global uptake of immunization against diseases and viruses including Covid-19, a study shows.

26 Oct 2021

How pregnancy influences SARS-CoV-2 immune response

A focus article published in Science Translational Medicine highlighted two recently published studies that investigated the response of pregnant women to natural infections and COVID-19 vaccines.

25 Oct 2021

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

A new study posted to the medRxiv* preprint server studies the neutralizing antibody response in cancer patients diagnosed with chronic lymphocytic leukemia (CLL), lung cancer, breast cancer, and various non-Hodgkin’s lymphomas (NHL), post-reception of two doses of messenger RNA (mRNA) vaccines.

25 Oct 2021

CDC endorses ACIP's recommendation for COVID-19 booster shots in certain populations

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation for a booster shot of COVID-19 vaccines in certain populations.

22 Oct 2021

Development of a safe and effective COVID-19 nanoparticle vaccine

Researchers from ReVacc scientific have attempted to demonstrate the effectiveness of a new vaccine, REVC-128, two weeks post-administration.

22 Oct 2021

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.

22 Oct 2021

Nationwide advertising campaign launches in the UK to urge people to get COVID-19 booster, flu jabs

A nationwide advertising campaign launches today (Friday 22 October) as part of the government's call to the public to get their COVID-19 booster and flu jabs, to protect themselves and their loved ones this winter.

21 Oct 2021

Development of a plant-based platform for the production of SARS-CoV-2 antigen

Scientists have recently focused on the development of plant-based recombinant protein platforms.

21 Oct 2021

Innovative method greatly simplifies the complexity of delivering vaccines

Future vaccine delivery may rely on everyday items like BBQ lighters and microneedles, thanks to the ingenuity of a team of Georgia Institute of Technology and Emory University researchers.

21 Oct 2021

Broadly protective vaccines against coronaviruses needed to protect against future outbreaks

The coronavirus disease 2019 (COVID-19) pandemic, caused by the β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), alerted the world to the seriousness of the threat posed by novel viruses.

20 Oct 2021

The neutralization potential of nanobodies against SARS-CoV-2

A recent review describes the role of nanobodies as a new class of recombinant antibodies that are used in the treatment of COVID-19.

20 Oct 2021

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

A clinical study by a team of scientists from Norway aimed to assess the immunogenicity and safety of a third dose of COVID-19 mRNA vaccine in MS patients treated with anti-CD20 therapy or fingolimod. A preprint version of the study, which is yet to undergo peer review, is available on the medRxiv* server.

20 Oct 2021

SARS-CoV-2 antibodies detected in breast milk of vaccinated mothers

Now, a new medRxiv* preprint study finds mothers vaccinated either one of the messenger RNA (mRNA) vaccines transferred neutralizing antibodies and cytokines, including interferon-gamma (IFNγ), to a breastfeeding child. Additionally, the humoral response in breastmilk was effective in neutralizing four variants of concern.

18 Oct 2021

Study shows enhanced immunogenicity of heterologous boosting strategy in individuals primed with J&J vaccine

Researchers from Singapore conducted a study to assess the spike protein-specific humoral and cellular immunity in Ad26.COV2.S vaccinated individuals either primed with Ad26.COV2.S only, or boosted with a homologous or heterologous second dose.

18 Oct 2021

Accelerated regime of preventative drugs could prevent malaria infection and deaths in Africa

Malaria infection and deaths could be avoided by more than half a million young children thanks to an accelerated regime of preventative drugs being rolled in four African countries, says global health agency Unitaid.

18 Oct 2021

Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity

Should you get a second dose of the same vaccine if you’ve received the one-dose Johnson & Johnson shot? According to new clinical trial results published on the preprint medRxiv* server, a booster shot of a messenger RNA (mRNA) vaccine may increase your chances of neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Oct 2021

Schedule online visits first? It’s the next big thing in health insurance

At the height of the covid-19 pandemic, people often relied on telemedicine for doctor visits. Now, insurers are betting that some patients liked it enough to embrace new types of health coverage that encourages video visits — or outright insists on them.

15 Oct 2021

Immunization News and Research

Study: Understanding the reasons behind vaccine hesitancy is key to boosting global uptake of immunization

How pregnancy influences SARS-CoV-2 immune response

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

CDC endorses ACIP's recommendation for COVID-19 booster shots in certain populations

Development of a safe and effective COVID-19 nanoparticle vaccine

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Nationwide advertising campaign launches in the UK to urge people to get COVID-19 booster, flu jabs

Development of a plant-based platform for the production of SARS-CoV-2 antigen

Innovative method greatly simplifies the complexity of delivering vaccines

Broadly protective vaccines against coronaviruses needed to protect against future outbreaks

The neutralization potential of nanobodies against SARS-CoV-2

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

SARS-CoV-2 antibodies detected in breast milk of vaccinated mothers

Study shows enhanced immunogenicity of heterologous boosting strategy in individuals primed with J&J vaccine

Accelerated regime of preventative drugs could prevent malaria infection and deaths in Africa

Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity

Schedule online visits first? It’s the next big thing in health insurance

Prior immunity to influenza, not SARS-CoV-2, prevents severe disease and mortality

Inactivated polio vaccine induces antibodies that block SARS-CoV-2 RNA synthesis

Low risk of severe COVID-19 after first dose of Pfizer and AstraZeneca vaccines in Scotland

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News